This is consistent with the findings that higher GPX2 expression is associated with worse RFS in CCS3 CRC and inconsistent with the apparent isolation of low-expressing cell lines from CCS3 tumors (Figure 8) [56]. This evidence concerns the gene GPX2 and colorectal carcinoma.